Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Napo Pharmaceuticals, Inc.

Clinical trials sponsored by Napo Pharmaceuticals, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for kids with MVID: drug aims to cut diarrhea and IV needs Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

New hope for kids with MVID: drug aims to cut diarrhea and IV needs

Disease control Ongoing

This study tests a drug called crofelemer in 6 children with microvillus inclusion disease (MVID), a rare condition causing severe diarrhea and dependence on IV fluids. The drug is given as a powder mixed with water, three times a day, and compared to a placebo. The goal is to se…

Phase 2/3 • Sponsor: Napo Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 13:05 UTC